Home Newsfeeds Piper Sandler Upgrades Alkermes to Overweight, Raises Price Target to $30

Piper Sandler Upgrades Alkermes to Overweight, Raises Price Target to $30

Piper Sandler analyst David Amsellem upgrades Alkermes (NASDAQ:ALKS) from Neutral to Overweight and raises the price target from $26 to $30.

byBenzinga Newsdesk

November 3, 2022

1 minute read

Piper Sandler analyst David Amsellem upgrades Alkermes (NASDAQ:ALKS) from Neutral to Overweight and raises the price target from $26 to $30.

Teleflex’s Interventional Urology Portfolio Expansion Earns Overweight Rating From Bullish Analyst

By Nabaparna Bhattacharya

July 27, 3:29 PM

Stephens analyst George Sellers reiterated an Overweight rating on Teleflex Incorporated (NYSE: TFX),

TFX

Analyst Ratings

4 Analysts Have This to Say About Monolithic Power Systems

By Benzinga Insights

August 2, 10:29 AM

Over the past 3 months, 4 analysts have published their opinion on Monolithic Power Systems (NASDAQ:MPWR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

MPWR

News

TRxADE HEALTH, Inc., Launches TRxADE Prime Plus Program

By Bill Haddad

August 30, 8:31 AM

TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company") an integrated drug procurement, delivery, and healthcare marketplace platform that connects buyers and sellers, today announced the launch

MEDS